Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND)

NCT01394952 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

9901

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiovascular Disease
Diabetes Mellitus, Type 2

Interventions

DRUG: Dulaglutide
DRUG: Placebo

Sponsor

Eli Lilly and Company